细菌耐药性研究进展

doi:10.16431/j.cnki.1671-7236.2015.12.038

摘要/Abstract

摘要： 细菌抗生素类药物耐药性的产生是临床治疗感染性疾病的一大难题,已受到人们的广泛关注。细菌主要通过产生灭活酶或钝化酶获得耐药性,除此之外还有细胞壁的渗透障碍、外排泵的泵出作用、靶位改变等多种机制,这些机制相互作用共同决定细菌的耐药水平。随着新型抗生素的临床应用,新的耐药机制随之出现,耐药菌也越来越广泛。细菌耐药机制的研究对耐药菌的控制和新药开发具有指导性意义。文章从耐药性的起源、产生机理、耐药特性及耐药性的检测方法4个方面进行了阐述。

关键词: 细菌; 抗生素; 耐药性; 耐药机制

Abstract: Antibiotic resistance of bacteria is a major problem in the clinical treatment of infectious diseases,and it has received the extensive attention.Bacteria producing inactivated enzyme or passivated enzyme is a mainly way to acquire resistance.Besides,the mechanisms of cell wall permeability barrier,efflux pump and target changes are existed,these mechanisms interact to the level of the bacterial antibiotic resistance.With the clinical application of new antibiotic,the new resistant mechanisms emerge and the antibiotic-resistant bacteria are widespread.The study of bacterial resistance mechanisms has instructional meaning for antibiotic-resistant bacteria control and new drug development.We elaborated the bacterial resistance from the origin of the resistance,mechanisms,characteristics and test method in this article.

Key words: bacteria; antibiotics; resistance; resistance mechanism

中图分类号:

S852.61

朱阵, 曹明泽, 张吉丽, 周绪正, 李冰, 张继瑜. 细菌耐药性研究进展[J]. , 2015, 42(12): 3371-3376.

ZHU Zhen, CAO Ming-ze, ZHANG Ji-li, ZHOU Xu-zheng, LI Bing, ZHANG Ji-yu. Research Progress on Bacterial Resistance[J]. , 2015, 42(12): 3371-3376.

参考文献

[1] 赵明秋,沈海燕,潘文,等.细菌耐药性产生的原因、机制及防治措施[J].中国畜牧兽医,2011,38(5):177-181.
[2] Casali N,Nikolayevskyy V,Balabanova Y,et al.Microevolution of extensively drug-resistant tuberculosis in Russia[J].Genome Res,2012,22(4):735-745.
[3] Gandhi N R,Nunn P,Dheda K,et al.Multidrug-resistant and extensively drug-resistant tuberculosis:A threat 200 to global control of tuberculosis[J].Lancet,2010,375(9728):1830-1843.
[4] Martinez J L,Baquero F.Emergence and spread of antibiotic resistance:Setting a parameter space[J].Ups J Med Sci,2014,119(2):68-77.
[5] Riesenfeld C S,Goodman R M,Handelsman J.Uncultured soil bacteria are a reservoir of new antibiotic resistance genes[J].Environ Microbiol,2004,6(9):981-989.
[6] Martinez J L,Sanchez M B,Martinez-Solano L,et al.Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems[J].FEMS Microbiol Rev,2009,33(2):430-449.
[7] 刘五高,丁友法,刘爱霞,等.质粒介导的耐药基因水平传播研究进展[J].中国卫生检验杂志,2015,25(8):1288-1296.
[8] Hudson L O,Murphy C R,Spratt B G,et al.Differences in methicillin-resistant Staphylococcus aureus strains isolated from pediatric and adult patients from hospitals in a large county in California[J].J Clin Microbiol,2012,50(3):573-579.
[9] Pfeifer Y,Cullik A,Witte W.Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens[J].Int J Med Microbiol,2010,300(6):371-379.
[10] Medeiros A A.Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics[J].Clin Infect Dis,1997,24(1):19-45.
[11] Nichols D A,Renslo A R,Chen Y.Fragment-based inhibitor discovery against β-lactamase[J].Future Med Chem,2014,6(4):413-427.
[12] Olsen I.New promising β-lactamase inhibitors for clinical use[J].Eur J Clin Microbiol Infect Dis,2015,34(7):1303-1308.
[13] 朱阵,王婧,刘翠翠,等.细菌对β-内酰胺类抗生素耐药机制研究进展[J].中国畜牧兽医,2014,41(7):238-242.
[14] Lahlaoui H,Ben Haj Khalifa A,Ben Moussa M.Epidemiology of Enterobacteriaceae producing CTX-M type extended spectrum β-lactamase (ESBL)[J].Med Mal Infect,2014,44(9):400-404.
[15] 俞云松.超广谱β-内酰胺酶研究进展[J].中华医学杂志,2006,86(9):641-644.
[16] 王艺颖.氯霉素乙酰转移酶突变体检测氯霉素[D].上海:华东师范大学,2005.
[17] Shaw W V,Leslie A G.Chloramphenicol acetyltransferase[J].Annu Rev Biophys Biophys Chem,1991,20:363-386.
[18] Deris J B,Kim M,Zhang Z,et al.The innate growth bistability and fitness landscapes of antibiotic-resistant bacteria[J].Science,2013,324(6162):1237435.
[19] 李红玉,邹全明.氨基糖苷类钝化酶耐药机制的研究进展[J].国外医学药学分册,2005,32(3):199-203.
[20] Azucena E,Mobashery S.Aminoglycoside-modifying enzymes:Mechanisms of catalytic processes and inhibition[J].Drug Resist Updut,2001,4(2):106.
[21] Dalhoff K.Worldwide guidelines for respiratory tract infections:Community-acquired pneumonia[J].Int J Antimicrob Agents,2001,18(Suppl 1):39-44.
[22] 明德松,吴一波,朱焱,等.耐甲氧西林葡萄球菌对大环内酯类抗生素的耐药机制[J].世界感染杂志,2006,6(2):140-141.
[23] 喻华,杨楠,黄文力.耐甲氧西林金葡色葡萄球菌研究进展[J].世界感染杂志,2006,6(3):187-189.
[24] 王睿,柴栋.细菌耐药机制与临床治疗对策[J].国外医药抗生素分册,2003,24(3):97-126.
[25] 雷连成,韩文瑜,段艳.大肠杆菌耐药性抑制剂作用机制的初步研究[J].中国兽药杂志,2004,38(2):18-21.
[26] Alcaraz A,Queralt-Martm M,García-Giménez E,et al.Increased salt concentration promotes competitive block of OmpF channel by protons[J].Biochim Biophys Acta,2012,1818(11):2777-2782.
[27] Ziervogel B K,Roux B.The binding of antibiotics in OmpF porin[J].Structure,2013,21(1):76-87.
[28] Nikaido H.Outer membrane barrier as a mechanism antimicrobial resistance[J].Antimicrob Agents Chemother,1989,33(11):1831-1836.
[29] Aygül A.The importance of efflux systems in antibiotic resistance and efflux pump inhibitors in the management of resistance[J].Mikrobiyol Bul,2015,49(2):278-291.
[30] Du D,van Veen H W,Luisi B F.Assembly and operation of bacterial tripartite multidrug efflux pumps[J].Trends Microbiol,2015,23(5):311-319.
[31] Sekiya H,Mima T,MoritaY,et al.Functional cloning and characterization of a multidrug efflux pump,mexHI-opmD,from a Pseudomonas aeruginosa mutant[J].Antimicroh Agents Chcmother,2003,47(9):2990-2992.
[32] Poole K.Efflux-mediated antimicrobial resistance[J].J Antimicrob Chemother,2005,56(1):20-51.
[33] 刘云婷,宋蕊.细菌的耐药性及其控制对策[J].黑龙江科技信息,2011,3:72.
[34] Hricová K,Kolář M.Bacterial efflux pumps——Their role in antibiotic resistance and potential inhibitors[J].Klin Mikrobiol Infekc Lek,2014,20(4):116-120.
[35] Nguyen S T,Kwasny S M,Ding X,et al.Structure-activity relationships of a novel pyranopyridine series of gram-negative bacterial efflux pump inhibitors[J].Bioorg Med Chem,2015,23(9):2024-2034.
[36] Ho P L,Yam W C,Que T L,et al.Target site modifications and efflux phenotype in clinical isolates of Streptococcus pneumoniae from Hong Kong with reduced susceptibility to fluoroquinolones[J].J Autimicroh Chemother,2001,47(5):655.
[37] Stapleton P D,Taylor P W.Methicillin resistance in Staphylococcus aureus:Mechanisms and modulation[J].Sci Prod,2002,85(1):57.
[38] Martinez-Martinez L,Eliecer C M,Manuel Rodriguez-Martinez J,et al.Plasmid mediated quinolone resistance[J].Expert Rev Anti Infect Ther,2008,6(5):685-711.
[39] 李继安,陈代杰.细菌耐药性机制的研究与新药开发Ⅱ 药物作用靶位被修饰或发生突的耐药机制与新药研究[J].国外医药,2001,22(3):132-136.
[40] 杨华为,蒋迪,王璨,等.细菌鉴定和耐药性检测方法的发展[J].临床药物治疗杂志,2006,4(4):39-44.
[41] 马秀清,陈良安.细菌耐药性检测方法的研究进展[J].解放军医学院学报,2015,36(4):404-407.